-
ABOUT USAffiliated to SSY Group Limited, Hebei Guangxiang Technology Co., Ltd., is a high-tech enterprise specializing in drug research and technology development.
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the synergy between “industry, academia, research and application” based on multi-disciplinary integration and multi-directional combination.
-
SUBORDINATEThe group has decided to establish research institutes in its subsidiaries, Hebei Ghuangxiang Drug Research Institute, Jiangsu Best Medical Material Research Institute, and Hebei Hanlin Biological Research Institute.
-
RECRUITWe actively establish a joint talent cultivation mechanism between schools and enterprises, and currently have over 500 high-level talents in various fields such as drug research, analysis, and clinical practice.
-
CONTACTWe will continue to strengthen innovation-driven development, vigorously promote the integration of production and research, constantly improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs.
Shijiazhuang Sihua Pharmaceutical Group: Gathering full energy for rapid development and making every effort to sprint through the third quarter.
Category:
Time：2022-09-08
Shijiazhuang Fourth Pharmaceutical is coordinating efforts to ensure smooth dual-circulation in both domestic and international markets. With full vigor, the company is accelerating the pace of production organization, market supply assurance, scientific research and development, and project construction, making every effort to deliver a strong finish in the third quarter and contributing wholeheartedly to helping the city achieve an economic aggregate exceeding one trillion yuan.
On September 7, at the high-tech zone production workshop of Shijiazhuang Sihua Pharmaceutical Group, every production line was bustling with activity.
Shijiazhuang No.4 Pharmaceutical is coordinating efforts to foster the dual circulation of domestic and international markets, stepping up its momentum and accelerating the pace of production organization, market supply assurance, scientific research and development, and project construction. The company is making every effort to deliver a strong finish in the third quarter and contributing wholeheartedly to helping the city achieve an economic aggregate exceeding one trillion yuan. From January to August this year, Shijiazhuang No.4 Pharmaceutical Group saw double-digit growth in both sales revenue and profits and taxes.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Mobile site
E code
Business license